Zemplar (paricalcitol) Capsule Logo
Abbott: A Promise for Life
Indication and Important Safety Information | Prescribing Information | Contact Us

  • Zemplar Home
  • Capsule HCP Home
  • Disease Information
  • About Zemplar Capsules
  • Professional Resources
  • For Your Patients
  • Request More Information
  • Indication and Important Safety Information
  • Full Prescribing Information
Abbott Global
Site Updates
  • Sign up today to receive Zemplar.com news updates.
  • Sign Up Now Go
Inside Man
Zemplar News
Back to Web Page Go |  Print This Page Go

Zemplar News

For the latest Zemplar news, click on the press release you wish to view:

  • Abbott Announces FDA Approval of Zemplar® (paricalcitol) Capsules for Earlier Treatment of Kidney Disease Complication (May 27, 2005)
  • Abbott Presents Promising Zemplar® (paricalcitol) Capsules Phase III Data Showing Potential for Earlier Treatment of Kidney Disease Complication (May 3, 2005)

Please click here for full prescribing information.

Inside Man
Helpful Tools
  • Print This Page
  • Email to a Colleague
  • Request More Information
  • Submit Feedback
  • Zemplar News
Healthcare Disparities
www.HCDinCKD.com

Indication and Important Safety Information | Prescribing Information

Home | Terms of Use | Privacy Policy | Site Map | Contact Us

Copyright © 2007 Abbott Laboratories. Abbott Park, Illinois, U.S.A.